Incidence of AD may decline in the early 90s for men, later for women: The Cache County study

Neurology. 2002 Jan 22;58(2):209-18. doi: 10.1212/wnl.58.2.209.

Abstract

Objectives: To characterize the incidence of AD among the elderly population of Cache County, UT, noted for its longevity and high response rates; to explore sex differences; and to examine whether AD incidence plateaus or declines in extreme old age.

Methods: Using a multistage screening process in 1998 and 1999, and re-examining 122 individuals who had been identified 3 years earlier as cognitively compromised but not demented, the authors found 185 individuals with incident dementia (123 with AD) among 3,308 participants who contributed 10,541 person-years of observation. Adjusting for nonresponse and screening sensitivity, the authors estimated the incidence of dementia and of AD for men and women in 3-year age intervals. Multivariate discrete time survival analysis was used to examine influences of age, sex, education, and genotype at APOE, as well as interactions of these factors.

Results: The incidence of both dementia and AD increased almost exponentially until ages 85 to 90, but appeared to decline after age 93 for men and 97 for women. A statistical interaction between age and the presence of two APOE-epsilon 4 alleles indicated acceleration in onset of AD with this genotype; the interaction of age and one epsilon 4 suggested more modest acceleration. A statistical interaction of sex and age indicated greater incidence of AD in women than in men after age 85.

Conclusions: The incidence of AD in the Cache County population increased with advancing age, but then peaked and declined among the extremely old. The presence of APOE-epsilon 4 alleles accelerated onset of AD, but did not appreciably alter lifetime incidence apparent over a span of 100 years.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Age Factors
  • Aged
  • Aged, 80 and over
  • Alleles
  • Alzheimer Disease / diagnosis
  • Alzheimer Disease / epidemiology*
  • Alzheimer Disease / genetics
  • Apolipoprotein E4
  • Apolipoproteins E / genetics*
  • Dementia / diagnosis
  • Dementia / epidemiology
  • Diagnosis, Differential
  • Female
  • Humans
  • Incidence
  • Male
  • Mass Screening
  • Reproducibility of Results
  • Sex Factors
  • Surveys and Questionnaires
  • Utah / epidemiology

Substances

  • Apolipoprotein E4
  • Apolipoproteins E